Matches in Nanopublications for { ?s ?p "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP795907.RACSsICCvKYqUrG7iTI4JBfA7_4hA1yEpxvBY6_mGQBdo130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795907.RACSsICCvKYqUrG7iTI4JBfA7_4hA1yEpxvBY6_mGQBdo130_provenance.
- NP316014.RAkRMrFHI2VZP69XZ6FiayFY_9EIu_ib79ytgtWM9kBHc130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316014.RAkRMrFHI2VZP69XZ6FiayFY_9EIu_ib79ytgtWM9kBHc130_provenance.
- NP487326.RA5CfBQYilhY60km_WDDvCUEqd1fPk0H4uDwKXWc-rhwg130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487326.RA5CfBQYilhY60km_WDDvCUEqd1fPk0H4uDwKXWc-rhwg130_provenance.
- assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1059228.RAGyJn_0Ud-yMGl3lYQbvpyt53Sbbvyw5pFIXNqqp0Vi0130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1059228.RAGyJn_0Ud-yMGl3lYQbvpyt53Sbbvyw5pFIXNqqp0Vi0130_provenance.
- NP1059227.RAy9p-jS9LKWyhdEzBVXS1QY4uYvtxJt4QRXHq6_U-Ed0130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1059227.RAy9p-jS9LKWyhdEzBVXS1QY4uYvtxJt4QRXHq6_U-Ed0130_provenance.
- NP887183.RA96yUwveS1q178f45WnrdTqQxerBl-JsAfbNa9Jwlm5k130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887183.RA96yUwveS1q178f45WnrdTqQxerBl-JsAfbNa9Jwlm5k130_provenance.
- NP887216.RA_B-pSMoUM4BIrcZVkbae1tknsbUNxuZktNTXA59m-5g130_assertion description "[In addition, mutations in glycine-N-methyltransferase (GNMT) could be associated with a higher risk of hepatocellular carcinoma and liver disease due to an unbalanced S-adenosylmethionine (SAM)/S-adenosylhomocysteine (SAH) ratio, which leads to aberrant methylation reactions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP887216.RA_B-pSMoUM4BIrcZVkbae1tknsbUNxuZktNTXA59m-5g130_provenance.